glp-1 and parkinson's disease Agonists: A New Frontier in Parkinson’s Treatment? GLP-1 Receptor Agonists: A New

2.3.5 Gut microbiota-based therapeutic interventions 2.3.5.1 FMT There is growing interest in using FMT as a possible treatment for ALS, based on encouraging early research

Review exogenous steroids that could cause adrenal insufficiency (if a dose is missed)

So when I found out I had the MTHFR gene variantwhich affects folate metabolismI jumped into high-dose B-complex supplements with both feet

Debate: Should Patients with BRAFmut metastatic melanoma get a BRAF+/- MEK inhibitor first-line

No Pressure, Just Professional Advice Youll leave your consultation either: Confident this treatment is right for you, or Aware of better alternatives for your goals Natural-Looking Results Our treatment plans prioritise gradual, authentic improvement over dramatic but short-lived changes

We dont need to manage everything, but we need to communicate and coordinate